Location History:
- Mittelweg, CH (2012)
- Münchenstein, CH (2012)
Company Filing History:
Years Active: 2012
Title: Thomas Leutert: Innovator in MMP Inhibitors
Introduction
Thomas Leutert is a notable inventor based in Mittelweg, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective hydroxamate-based MMP inhibitors. With a total of 2 patents, his work focuses on addressing disorders characterized by abnormal activity of matrix metalloproteinases (MMPs).
Latest Patents
Leutert's latest patents include innovative compounds that serve as inhibitors of MMP-9, MMP-12, and MMP-13. These compounds are designed to be employed in the treatment of various disorders or diseases mediated by these MMPs. The inventions also encompass pharmaceutical compositions that enhance the efficacy of these treatments.
Career Highlights
Throughout his career, Thomas Leutert has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Leutert has collaborated with notable professionals in his field, including Jonathan E. Grob and Ruben Alberto Tommasi. These collaborations have likely enriched his research and development efforts.
Conclusion
Thomas Leutert stands out as an influential inventor in the realm of MMP inhibitors, with a focus on advancing treatments for diseases linked to abnormal MMP activity. His contributions continue to impact the pharmaceutical landscape positively.